Lv4
420 积分 2024-02-01 加入
Molecular profiling of Chinese R-CHOP treated DLBCL patients: Identifying a high-risk subgroup
5天前
已完结
Circulating Tumor DNA as Measurable Residual Disease in Aggressive B-Cell Lymphoma: A Narrative Review
5天前
已完结
Circulating tumor DNA from blood and cerebrospinal fluid in DLBCL: simultaneous evaluation of mutations, IG rearrangement, and IG clonality
17天前
已完结
Circulating Tumor DNA as Measurable Residual Disease in Aggressive B-Cell Lymphoma
1个月前
已完结
The global burden of COPD: epidemiology and effect of prevention strategies
2个月前
已完结
A phase Ib/II combination of acalabrutinib with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone (R-CHOP) for patients with diffuse large B-cell lymphoma (DLBCL)". Cancer research (Chicago, Ill.)
2个月前
已关闭
Deciphering the Prognostic Significance of MYD88 and CD79B Mutations in Diffuse Large B-Cell Lymphoma: Insights into Treatment Outcomes
3个月前
已完结
Diffuse Large B-Cell Lymphoma and High-Grade B-Cell Lymphoma: Genetic Classification and Its Implications for Prognosis and Treatment
3个月前
已完结
The Prognostic Significance of CD79B Mutation in Diffuse Large B-Cell Lymphoma: A Meta-analysis and Systematic Literature Review
3个月前
已完结
Genomic characterisation of diffuse large B-cell lymphoma
3个月前
已完结
皖公网安备34019202002308
